GBLX - GB Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 528.51M
Enterprise Value 345.6M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.35
Price/Book (mrq)3.75
Enterprise Value/Revenue 314.95
Enterprise Value/EBITDA 6-3.46

Trading Information

Stock Price History

Beta (3Y Monthly) 0.39
52-Week Change 3-71.57%
S&P500 52-Week Change 31.68%
52 Week High 30.4500
52 Week Low 30.0800
50-Day Moving Average 30.1200
200-Day Moving Average 30.1546

Share Statistics

Avg Vol (3 month) 3544.99k
Avg Vol (10 day) 3766.64k
Shares Outstanding 5246.25M
Float 221.17M
% Held by Insiders 110.40%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Oct 31, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-453.98%

Management Effectiveness

Return on Assets (ttm)-29.47%
Return on Equity (ttm)-123.20%

Income Statement

Revenue (ttm)3.05M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-30.80%
Gross Profit (ttm)208.46k
EBITDA -13.17M
Net Income Avi to Common (ttm)-23.75M
Diluted EPS (ttm)-0.1050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)141.31k
Total Cash Per Share (mrq)0
Total Debt (mrq)11.22M
Total Debt/Equity (mrq)71.88
Current Ratio (mrq)0.45
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-8.56M
Levered Free Cash Flow (ttm)-11.38M